Cytosorbents CTSO
NASDAQ CTSO
$5.34 -0.46 (-7.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Cytosorbents (CTSO) Amortization of Deferred Charges (2009 - 2026)

Updated

Cytosorbents' Amortization of Deferred Charges was $97,041 in FY2018, up 18.3% from $82,054 in FY2017.

Analysis

Cytosorbents (CTSO) Amortization of Deferred Charges (2009 - 2026) Analysis & Trends

  • Per Business Quant data, Amortization of Deferred Charges in earlier years was $82,054 in FY2017 (+169.2%) and $30,480 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Cytosorbents 2.28 Mn -20.73 Mn 7.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 282,000.00
Mar 31, 2026 291,000.00
Dec 31, 2025 249,000.00
Sep 30, 2025 190,000.00
Jun 30, 2025 191,000.00
Mar 31, 2025 190,000.00
Dec 31, 2024 127,000.00
Sep 30, 2024 46,000.00
Jun 30, 2024 46,073.00
Mar 31, 2024 45,927.00
Dec 31, 2023 398,035.00
Sep 30, 2023 55,440.00
Jun 30, 2023 55,442.00
Mar 31, 2023 55,439.00
Dec 31, 2022 55,441.00
Sep 30, 2022 64,522.00
Jun 30, 2022 64,522.00
Mar 31, 2022 64,523.00
Dec 31, 2021 398,035.00
Dec 31, 2020 215,208.00
API Access

Cytosorbents Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CTSO&period=max&api_key=YOUR_API_KEY